BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11925116)

  • 1. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer.
    Lebrecht A; Ludwig E; Huber A; Klein M; Schneeberger C; Tempfer C; Koelbl H; Hefler L
    Gynecol Oncol; 2002 Apr; 85(1):32-5. PubMed ID: 11925116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia.
    Dobbs SP; Hewett PW; Johnson IR; Carmichael J; Murray JC
    Br J Cancer; 1997; 76(11):1410-5. PubMed ID: 9400935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN).
    Bodner-Adler B; Hefler L; Bodner K; Leodolter S; Frischmuth K; Kainz C; Mayerhofer K
    Anticancer Res; 2001; 21(1B):809-12. PubMed ID: 11299848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-A [corrected].
    Mathur SP; Mathur RS; Gray EA; Lane D; Underwood PG; Kohler M; Creasman WT
    Gynecol Oncol; 2005 Sep; 98(3):467-83. PubMed ID: 15982726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?
    Dunst J; Pigorsch S; Hänsgen G; Hintner I; Lautenschläger C; Becker A
    Strahlenther Onkol; 1999 Mar; 175(3):93-6. PubMed ID: 10093609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma.
    Shimada H; Takeda A; Nabeya Y; Okazumi SI; Matsubara H; Funami Y; Hayashi H; Gunji Y; Kobayashi S; Suzuki T; Ochiai T
    Cancer; 2001 Aug; 92(3):663-9. PubMed ID: 11505413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease.
    Hammes LS; Tekmal RR; Naud P; Edelweiss MI; Kirma N; Valente PT; Syrjänen KJ; Cunha-Filho JS
    Gynecol Oncol; 2008 Sep; 110(3):445-51. PubMed ID: 18565574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of serum vascular endothelial growth factor, basic fibroblast growth factor and nitric oxide in patients with colorectal carcinoma.
    Akbulut H; Altuntas F; Akbulut KG; Ozturk G; Cindoruk M; Unal E; Icli F
    Cytokine; 2002 Nov; 20(4):184-90. PubMed ID: 12543084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.
    Coskun U; Günel N; Toruner FB; Sancak B; Onuk E; Bayram O; Cengiz O; Yilmaz E; Elbeg S; Ozkan S
    Neoplasma; 2003; 50(1):41-6. PubMed ID: 12687277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer.
    Matsuyama W; Hashiguchi T; Mizoguchi A; Iwami F; Kawabata M; Arimura K; Osame M
    Chest; 2000 Oct; 118(4):948-51. PubMed ID: 11035661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF and CD105 immunoexpression in squamous cervical carcinomas and associated precancerous lesions.
    Stepan D; Simionescu C; Stepan A; Muntean M; Voinea B
    Rom J Morphol Embryol; 2012; 53(3):585-9. PubMed ID: 22990551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum VEGF levels in patients undergoing primary radiotherapy for cervical cancer: impact on progression-free survival.
    Bachtiary B; Selzer E; Knocke TH; Pötter R; Obermair A
    Cancer Lett; 2002 May; 179(2):197-203. PubMed ID: 11888674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor in the progression of cervical neoplasia and its relation to angiogenesis and p53 status.
    Lee JS; Kim HS; Park JT; Lee MC; Park CS
    Anal Quant Cytol Histol; 2003 Dec; 25(6):303-11. PubMed ID: 14714296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate markers of tumoral angiogenesis.
    Byrne GJ; Bundred NJ
    Int J Biol Markers; 2000; 15(4):334-9. PubMed ID: 11192830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of vascular endothelial growth factor in vulvar cancer.
    Hefler L; Tempfer C; Obermair A; Frischmuth K; Sliutz G; Reinthaller A; Leodolter S; Kainz C
    Clin Cancer Res; 1999 Oct; 5(10):2806-9. PubMed ID: 10537345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The correlation between immunohistochemically-detected markers of angiogenesis and serum vascular endothelial growth factor in patients with breast cancer.
    Lantzsch T; Hefler L; Krause U; Kehl A; Goepel C; Koelbl H; Dunst J; Lampe D
    Anticancer Res; 2002; 22(3):1925-8. PubMed ID: 12168895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ; Li JR; Li ZB
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
    Peng XP; Li JD; Li MD; Ye XM; Yan WC
    Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor expression in progression of cervical cancer: correlation with thymidine phosphorylase expression, angiogenesis, tumor cell proliferation, and apoptosis.
    Fujiwaki R; Hata K; Iida K; Maede Y; Miyazaki K
    Anticancer Res; 2000; 20(2B):1317-22. PubMed ID: 10810442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer.
    Tamura M; Ohta Y; Kajita T; Kimura K; Go T; Oda M; Nakamura H; Watanabe G
    Oncol Rep; 2001; 8(5):1097-102. PubMed ID: 11496323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.